Tumor-Associated Macrophages Promote Invasion while Retaining Fc-Dependent Anti-Tumor Function

被引:84
|
作者
Grugan, Katharine D. [1 ]
McCabe, Francis L. [2 ]
Kinder, Michelle [1 ]
Greenplate, Allison R. [1 ]
Harman, Benjamin C. [1 ]
Ekert, Jason E. [1 ]
van Rooijen, Nico [3 ]
Anderson, G. Mark [2 ]
Nemeth, Jeffrey A. [2 ]
Strohl, William R. [1 ]
Jordan, Robert E. [1 ]
Brezski, Randall J. [1 ]
机构
[1] Janssen Res & Dev, Biol Res, Radnor, PA 19087 USA
[2] Janssen Res & Dev, Oncol Res, Radnor, PA 19087 USA
[3] Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol, NL-1007 MB Amsterdam, Netherlands
来源
JOURNAL OF IMMUNOLOGY | 2012年 / 189卷 / 11期
关键词
ANTI-CD20; MONOCLONAL-ANTIBODY; IN-VITRO; STIMULATING FACTOR; BREAST-CANCER; CD20; IMMUNOTHERAPY; LYMPHOMA DEPLETION; EFFECTOR FUNCTIONS; MAMMARY-TUMORS; T-CELLS; GAMMA;
D O I
10.4049/jimmunol.1201889
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Tumor-associated macrophages (TAMs) have been shown to promote tumor progression, and increased TAM infiltration often correlates with poor prognosis. However, questions remain regarding the phenotype of macrophages within the tumor and their role in mAb-dependent cytotoxicity. This study demonstrates that whereas TAMs have protumor properties, they maintain Fc-dependent anti-tumor function. CD11b(+)CD14(+) TAMs isolated from primary human breast tumors expressed activating Fc gamma Rs. To model breast cancer TAMs in vitro, conditioned medium from breast cancer cells was used to drive human peripheral monocyte differentiation into macrophages. Tumor-conditioned macrophages were compared with in vitro derived M1 and M2a macrophages and were found to promote tumor cell invasion and express M2a markers, confirming their protumor potential. However, unlike M2a macrophages, tumor-conditioned macrophages expressed Fc gamma Rs and phagocytosed tumor cells in the presence of a tumor Ag-targeting mAb, unmasking an underappreciated tumoricidal capacity of TAMs. In vivo macrophage depletion reduced the efficacy of anti-CD142 against MDA-MB-231 xenograft growth and metastasis in SCID/beige mice, implicating a critical role for macrophages in Fc-dependent cell killing. M-CSF was identified in tumor-conditioned media and shown to be capable of differentiating macrophages with both pro-and anti-tumor properties. These results highlight the plasticity of TAMs, which are capable of promoting tumor progression and invasion while still retaining tumoricidal function in the presence of tumor-targeting mAbs. The Journal of Immunology, 2012, 189: 5457-5466.
引用
收藏
页码:5457 / 5466
页数:10
相关论文
共 50 条
  • [21] Targeting macrophages to promote anti-tumor immunity.
    Varner, Judith A.
    CANCER IMMUNOLOGY RESEARCH, 2021, 9 (02)
  • [22] Tumor-associated macrophages in nanomaterial-based anti-tumor therapy: as target spots or delivery platforms
    Zheng, Jixuan
    Jiang, Jinting
    Pu, Yicheng
    Xu, Tingrui
    Sun, Jiantong
    Zhang, Qiang
    He, Ling
    Liang, Xiao
    FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2023, 11
  • [23] Tumor-associated macrophages (TAMs) depend on Shp2 for their anti-tumor roles in colorectal cancer
    Wang, Saisai
    Yao, Yuanyuan
    Li, Huixia
    Zheng, Gang
    Lu, Sen
    Chen, Wenbin
    AMERICAN JOURNAL OF CANCER RESEARCH, 2019, 9 (09): : 1957 - +
  • [24] Dectin-2 agonist antibodies reprogram tumor-associated macrophages to drive anti-tumor immunity
    Kenkel, Justin A.
    Ho, Po Y.
    Henning, Karla A.
    Kreder, Cindy L.
    Nolin, Jess L.
    Kongara, Sameera
    Chapin, Steven J.
    Husain, Amreen
    Kowanetz, Marcin
    Engleman, Edgar G.
    Alonso, Michael N.
    Dornan, David
    Ackerman, Shelley E.
    CANCER RESEARCH, 2022, 82 (12)
  • [25] Targeting cGAS-STING pathway for reprogramming tumor-associated macrophages to enhance anti-tumor immunotherapy
    Zhang, Weiyue
    Huang, Xin
    BIOMARKER RESEARCH, 2025, 13 (01)
  • [26] Depletion of tumor-associated macrophages enhances the anti-tumor effect of docetaxel in a murine epithelial ovarian cancer
    Lu, Xiaofen
    Meng, Tengteng
    IMMUNOBIOLOGY, 2019, 224 (03) : 355 - 361
  • [27] Immunostimulation of tumor microenvironment by targeting tumor-associated macrophages with hypoxia-responsive nanocomplex for enhanced anti-tumor therapy
    Kang, Yeoul
    Lim, Junha
    Saravanakumar, Gurusamy
    Kim, Jinseong
    Park, Mihyeon
    Im, Sooseok
    Kim, Won Jong
    JOURNAL OF CONTROLLED RELEASE, 2022, 343 : 78 - 88
  • [28] Immunostimulation of tumor microenvironment by targeting tumor-associated macrophages with hypoxia-responsive nanocomplex for enhanced anti-tumor therapy
    Kang, Yeoul
    Lim, Junha
    Saravanakumar, Gurusamy
    Kim, Jinseong
    Park, Mihyeon
    Im, Sooseok
    Kim, Won Jong
    Journal of Controlled Release, 2022, 343 : 78 - 88
  • [29] Tumor-associated macrophages. Function and differentiation
    Niedobitek, G.
    Barros, M. H.
    Dreyer, J. H.
    Hauck, F.
    Al-Sheikhyaqoob, D.
    PATHOLOGE, 2015, 36 (05): : 477 - 484
  • [30] FoxO1 is a regulator of MHC-II expression and anti-tumor effect of tumor-associated macrophages
    Yang, Jing-Bo
    Zhao, Zhi-Bin
    Liu, Qing-Zhi
    Hu, Tai-Dou
    Long, Jie
    Yan, Kai
    Lian, Zhe-Xiong
    ONCOGENE, 2018, 37 (09) : 1192 - 1204